Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.

QR Code

Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.

Alzheimer's disease (AD) and type 2 diabetes (T2D) present a significant risk to each other. AD and T2D are characterized by deposition of cerebral amyloid-ß (Aß) and pancreatic human islet amyloid polypeptide (hIAPP), respectively. We investigated the role of amyloidogenic proteins in the inte...

Full description

Bibliographic Details
Main Authors:	Wijesekara, N., Ahrens, R., Sabale, M., Wu, L., Ha, K., Verdile, Giuseppe, Fraser, P.
Format:	Journal Article
Published:	Federation of American Societies for Experimental Biology 2017
Online Access:	http://hdl.handle.net/20.500.11937/56653

Similar Items

The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-ß, Amylin, and Tau Proteins
by: Bharadwaj, Prashant, et al.
Published: (2017)

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

Alzheimer's amyloid-ß rescues yeast from hydroxide toxicity
by: Dubey, A., et al.
Published: (2009)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1ß 2 in type 2 diabetes
by: Masters, S., et al.
Published: (2010)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

Autoantibody-catalyzed hydrolysis of amyloid ß peptide
by: Taguchi, H., et al.
Published: (2008)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Luteinizing Hormone Levels Are Positively Correlated with Plasma Amyloid-ß Protein Levels in Elderly Men
by: Verdile, Giuseppe, et al.
Published: (2008)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

Enterocyte Beta Amyloid-Lipoprotein Homeostasis: Implications for Alzheimer's Disease Risk
by: Galloway, Susan
Published: (2015)

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
by: Xie, Ling, et al.
Published: (2002)

Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
by: Moore, S., et al.
Published: (2018)

Plasma lipoprotein b-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
by: Mamo, John, et al.
Published: (2008)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Molecular docking studies on the interaction of anti-alzheimer compounds with amyloid beta peptides
by: Faujan, Nur Hana, et al.
Published: (2019)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: Elaskalani, O., et al.
Published: (2017)

Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)

Modulation of amyloid-ß 1-42 structure and toxicity by proline-rich whey peptides
by: Bharadwaj, Prashant, et al.
Published: (2013)

Role of the cell membrane interface in modulating production and uptake of Alzheimer's beta amyloid protein
by: Bharadwaj, Prashant, et al.
Published: (2018)

Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)

Cerebral amyloid-ß accumulation and deposition following traumatic brain injury-A narrative review and meta-analysis of animal studies
by: Bird, S., et al.
Published: (2016)

Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation
by: Simioni, Elena, et al.
Published: (2017)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice
by: Takechi, Ryu, et al.
Published: (2009)

Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue
by: Sharif, Arazu
Published: (2024)

ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)

The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)

A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)

Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer’s disease
by: Barber, Imelda S., et al.
Published: (2016)

Screening exon 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease
by: Barber, Imelda S., et al.
Published: (2016)

Interactive Effects of Dietary Fat and APOE Genotype on Peripheral Amyloid-Beta: Implications for Alzheimer’s Disease Risk
by: D'Alonzo, Zachary John
Published: (2025)

Unveiling amyloid-β1–42 interaction with zinc in water and mixed hexafluoroisopropanol solution in Alzheimer’s disease
by: Ghani, Nur Syafiqah Abdul, et al.
Published: (2017)

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ofi4oprvb38dd4igf1u6444cos